Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | IKK16 | 2.0 | uM | 4 | b-NGF | 62.0 | 62 | ||||
RA2159 | IL-17A | 100 | ng/mL | 4 | b-NGF | 44.5 | 50 | ||||
RA2159 | EO1428 | 1.0 | uM | IL-17A | 100 | ng/mL | 4 | b-NGF | 45.0 | 62 | |
RA2159 | PI103 | 0.1 | uM | IL-17A | 100 | ng/mL | 4 | b-NGF | 45.0 | 71 | |
RA2159 | Sigma A6730 | 3.0 | uM | IL-17A | 100 | ng/mL | 4 | b-NGF | 45.5 | 72 | |
RA2159 | JNK-IN-8 | 3.0 | uM | IL-17A | 100 | ng/mL | 4 | b-NGF | 49.0 | 70 | |
RA2159 | JNK-IN-11 | 0.3 | uM | IL-17A | 100 | ng/mL | 4 | b-NGF | 36.0 | 45 | |
RA2159 | Tofacitinib | 0.3 | uM | 4 | b-NGF | 47.5 | 28 | ||||
N2586 | IL-17A | 100 | ng/mL | 4 | b-NGF | 128.0 | 41 | ||||
N2586 | EO1428 | 1.0 | uM | IL-17A | 100 | ng/mL | 4 | b-NGF | 137.0 | 62 | |
N2586 | PI103 | 0.1 | uM | IL-17A | 100 | ng/mL | 4 | b-NGF | 95.5 | 40 | |
N2586 | Sigma A6730 | 3.0 | uM | IL-17A | 100 | ng/mL | 4 | b-NGF | 100.5 | 46 | |
N2586 | JNK-IN-8 | 3.0 | uM | IL-17A | 100 | ng/mL | 4 | b-NGF | 79.5 | 58 | |
N2586 | JNK-IN-11 | 0.3 | uM | IL-17A | 100 | ng/mL | 4 | b-NGF | 72.0 | 66 | |
N2586 | Tofacitinib | 0.3 | uM | 4 | b-NGF | 49.5 | 50 | ||||
RA2159 | IL-6 | 100 | ug/mL | 4 | b-NGF | 60.0 | 71 | ||||
RA2159 | EO1428 | 1.0 | uM | IL-6 | 100 | ug/mL | 4 | b-NGF | 34.0 | 82 | |
RA2159 | PI103 | 0.1 | uM | IL-6 | 100 | ug/mL | 4 | b-NGF | 40.5 | 56 | |
RA2159 | Sigma A6730 | 3.0 | uM | IL-6 | 100 | ug/mL | 4 | b-NGF | 46.0 | 62 | |
RA2159 | JNK-IN-8 | 3.0 | uM | IL-6 | 100 | ug/mL | 4 | b-NGF | 33.0 | 53 | |
RA2159 | JNK-IN-11 | 0.3 | uM | IL-6 | 100 | ug/mL | 4 | b-NGF | 40.0 | 70 | |
RA2159 | Ruxolitinib | 0.3 | uM | 4 | b-NGF | 44.5 | 46 | ||||
N2586 | IL-6 | 100 | ug/mL | 4 | b-NGF | 98.0 | 57 | ||||
N2586 | EO1428 | 1.0 | uM | IL-6 | 100 | ug/mL | 4 | b-NGF | 111.0 | 62 | |
N2586 | PI103 | 0.1 | uM | IL-6 | 100 | ug/mL | 4 | b-NGF | 76.0 | 45 |